Replibio: Director and General Manager Xu Lei completes the purchase of 500,000 shares, representing 0.11% of the total share capital.

Repu Bio announces that the company's director and general manager, Xu Lei, increased his holdings in the company by 500,000 shares through block trading on June 16, 2026, representing 0.11% of the total share capital, at an average price of 14 yuan per share. The seller was Shen Lina, the concerted action person of Liang Wu, a shareholder holding more than 5% of the shares, who simultaneously transferred 500,000 shares of the company's stock to Xu Lei through block trading. Before the implementation of this transfer plan, Xu Lei held 164,800 shares of the company, accounting for 0.04% of the total share capital; after the transfer, he held 664,800 shares, accounting for 0.14% of the total share capital. Shen Lina held 2,073,300 shares before the transfer, accounting for 0.45% of the total share capital; after the transfer, she held 1,573,300 shares, accounting for 0.34% of the total share capital. The increase in holdings and transfer plan was disclosed in a pre-disclosure announcement on May 25, 2026, and has now been fully implemented.